Global Drugs for Prostate Cancer Market Professional Survey Report 2016
- QYR671785
- 100 Pages
- September 2016
- Pharmaceuticals
Production, means the output of Drugs for Prostate Cancer
Revenue, means the sales value of Drugs for Prostate Cancer
This report studies Drugs for Prostate Cancer in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Bristol-Myers Squibb
AstraZeneca
Eli Lilly
Roche
GSK
Novartis
Pfizer
Sanofi
Bayer
Celgene
By types, the market can be split into
Type I
Type II
Type III
By Application, the market can be split into
Application 1
Application 2
Application 3
By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India
Global Drugs for Prostate Cancer Market Professional Survey Report 2016
1 Industry Overview of Drugs for Prostate Cancer
1.1 Definition and Specifications of Drugs for Prostate Cancer
1.1.1 Definition of Drugs for Prostate Cancer
1.1.2 Specifications of Drugs for Prostate Cancer
1.2 Classification of Drugs for Prostate Cancer
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Applications of Drugs for Prostate Cancer
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 Manufacturing Cost Structure Analysis of Drugs for Prostate Cancer
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Drugs for Prostate Cancer
2.3 Manufacturing Process Analysis of Drugs for Prostate Cancer
2.4 Industry Chain Structure of Drugs for Prostate Cancer
3 Technical Data and Manufacturing Plants Analysis of Drugs for Prostate Cancer
3.1 Capacity and Commercial Production Date of Global Drugs for Prostate Cancer Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Drugs for Prostate Cancer Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Drugs for Prostate Cancer Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Drugs for Prostate Cancer Major Manufacturers in 2015
4 Global Drugs for Prostate Cancer Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2011-2016E Global Drugs for Prostate Cancer Capacity and Growth Rate Analysis
4.2.2 2015 Drugs for Prostate Cancer Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2016E Global Drugs for Prostate Cancer Sales and Growth Rate Analysis
4.3.2 2015 Drugs for Prostate Cancer Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2016E Global Drugs for Prostate Cancer Sales Price
4.4.2 2015 Drugs for Prostate Cancer Sales Price Analysis (Company Segment)
5 Drugs for Prostate Cancer Regional Market Analysis
5.1 North America Drugs for Prostate Cancer Market Analysis
5.1.1 North America Drugs for Prostate Cancer Market Overview
5.1.2 North America 2011-2016E Drugs for Prostate Cancer Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2011-2016E Drugs for Prostate Cancer Sales Price Analysis
5.1.4 North America 2015 Drugs for Prostate Cancer Market Share Analysis
5.2 China Drugs for Prostate Cancer Market Analysis
5.2.1 China Drugs for Prostate Cancer Market Overview
5.2.2 China 2011-2016E Drugs for Prostate Cancer Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2011-2016E Drugs for Prostate Cancer Sales Price Analysis
5.2.4 China 2015 Drugs for Prostate Cancer Market Share Analysis
5.3 Europe Drugs for Prostate Cancer Market Analysis
5.3.1 Europe Drugs for Prostate Cancer Market Overview
5.3.2 Europe 2011-2016E Drugs for Prostate Cancer Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2011-2016E Drugs for Prostate Cancer Sales Price Analysis
5.3.4 Europe 2015 Drugs for Prostate Cancer Market Share Analysis
5.4 Southeast Asia Drugs for Prostate Cancer Market Analysis
5.4.1 Southeast Asia Drugs for Prostate Cancer Market Overview
5.4.2 Southeast Asia 2011-2016E Drugs for Prostate Cancer Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2011-2016E Drugs for Prostate Cancer Sales Price Analysis
5.4.4 Southeast Asia 2015 Drugs for Prostate Cancer Market Share Analysis
5.5 Japan Drugs for Prostate Cancer Market Analysis
5.5.1 Japan Drugs for Prostate Cancer Market Overview
5.5.2 Japan 2011-2016E Drugs for Prostate Cancer Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2011-2016E Drugs for Prostate Cancer Sales Price Analysis
5.5.4 Japan 2015 Drugs for Prostate Cancer Market Share Analysis
5.6 India Drugs for Prostate Cancer Market Analysis
5.6.1 India Drugs for Prostate Cancer Market Overview
5.6.2 India 2011-2016E Drugs for Prostate Cancer Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2011-2016E Drugs for Prostate Cancer Sales Price Analysis
5.6.4 India 2015 Drugs for Prostate Cancer Market Share Analysis
6 Global 2011-2016E Drugs for Prostate Cancer Segment Market Analysis (by Type)
6.1 Global 2011-2016E Drugs for Prostate Cancer Sales by Type
6.2 Different Types of Drugs for Prostate Cancer Product Interview Price Analysis
6.3 Different Types of Drugs for Prostate Cancer Product Driving Factors Analysis
6.3.1 Type I Drugs for Prostate Cancer Growth Driving Factor Analysis
6.3.2 Type II Drugs for Prostate Cancer Growth Driving Factor Analysis
6.3.3 Type III Drugs for Prostate Cancer Growth Driving Factor Analysis
7 Global 2011-2016E Drugs for Prostate Cancer Segment Market Analysis (by Application)
7.1 Global 2011-2016E Drugs for Prostate Cancer Consumption by Application
7.2 Different Application of Drugs for Prostate Cancer Product Interview Price Analysis
7.3 Different Application of Drugs for Prostate Cancer Product Driving Factors Analysis
7.3.1 Application 1 Drugs for Prostate Cancer Growth Driving Factor Analysis
7.3.2 Application 2 Drugs for Prostate Cancer Growth Driving Factor Analysis
7.3.3 Application 3 Drugs for Prostate Cancer Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Drugs for Prostate Cancer
8.1 Bristol-Myers Squibb
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Type I
8.1.2.2 Type II
8.1.2.3 Type III
8.1.3 Bristol-Myers Squibb 2015 Drugs for Prostate Cancer Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Bristol-Myers Squibb 2015 Drugs for Prostate Cancer Business Region Distribution Analysis
8.2 AstraZeneca
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Type I
8.2.2.2 Type II
8.2.2.3 Type III
8.2.3 AstraZeneca 2015 Drugs for Prostate Cancer Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 AstraZeneca 2015 Drugs for Prostate Cancer Business Region Distribution Analysis
8.3 Eli Lilly
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Type I
8.3.2.2 Type II
8.3.2.3 Type III
8.3.3 Eli Lilly 2015 Drugs for Prostate Cancer Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Eli Lilly 2015 Drugs for Prostate Cancer Business Region Distribution Analysis
8.4 Roche
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Type I
8.4.2.2 Type II
8.4.2.3 Type III
8.4.3 Roche 2015 Drugs for Prostate Cancer Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Roche 2015 Drugs for Prostate Cancer Business Region Distribution Analysis
8.5 GSK
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Type I
8.5.2.2 Type II
8.5.2.3 Type III
8.5.3 GSK 2015 Drugs for Prostate Cancer Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 GSK 2015 Drugs for Prostate Cancer Business Region Distribution Analysis
8.6 Novartis
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Type I
8.6.2.2 Type II
8.6.2.3 Type III
8.6.3 Novartis 2015 Drugs for Prostate Cancer Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Novartis 2015 Drugs for Prostate Cancer Business Region Distribution Analysis
8.7 Pfizer
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Type I
8.7.2.2 Type II
8.7.2.3 Type III
8.7.3 Pfizer 2015 Drugs for Prostate Cancer Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Pfizer 2015 Drugs for Prostate Cancer Business Region Distribution Analysis
8.8 Sanofi
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Type I
8.8.2.2 Type II
8.8.2.3 Type III
8.8.3 Sanofi 2015 Drugs for Prostate Cancer Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Sanofi 2015 Drugs for Prostate Cancer Business Region Distribution Analysis
8.9 Bayer
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Type I
8.9.2.2 Type II
8.9.2.3 Type III
8.9.3 Bayer 2015 Drugs for Prostate Cancer Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Bayer 2015 Drugs for Prostate Cancer Business Region Distribution Analysis
8.10 Celgene
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Type I
8.10.2.2 Type II
8.10.2.3 Type III
8.10.3 Celgene 2015 Drugs for Prostate Cancer Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Celgene 2015 Drugs for Prostate Cancer Business Region Distribution Analysis
9 Development Trend of Analysis of Drugs for Prostate Cancer Market
9.1 Global Drugs for Prostate Cancer Market Trend Analysis
9.1.1 Global 2016-2021 Drugs for Prostate Cancer Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Drugs for Prostate Cancer Sales Price Forecast
9.2 Drugs for Prostate Cancer Regional Market Trend
9.2.1 North America 2016-2021 Drugs for Prostate Cancer Consumption Forecast
9.2.2 China 2016-2021 Drugs for Prostate Cancer Consumption Forecast
9.2.3 Europe 2016-2021 Drugs for Prostate Cancer Consumption Forecast
9.2.4 Southeast Asia 2016-2021 Drugs for Prostate Cancer Consumption Forecast
9.2.5 Japan 2016-2021 Drugs for Prostate Cancer Consumption Forecast
9.2.6 India 2016-2021 Drugs for Prostate Cancer Consumption Forecast
9.3 Drugs for Prostate Cancer Market Trend (Product Type)
9.4 Drugs for Prostate Cancer Market Trend (Application)
10 Drugs for Prostate Cancer Marketing Type Analysis
10.1 Drugs for Prostate Cancer Regional Marketing Type Analysis
10.2 Drugs for Prostate Cancer International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Drugs for Prostate Cancer by Regions
10.4 Drugs for Prostate Cancer Supply Chain Analysis
11 Consumers Analysis of Drugs for Prostate Cancer
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 Conclusion of the Global Drugs for Prostate Cancer Market Professional Survey Report 2016
Author List
Table Part of Interviewees Record List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
Figure Picture of Drugs for Prostate Cancer
Table Product Specifications of Drugs for Prostate Cancer
Table Classification of Drugs for Prostate Cancer
Figure Global Production Market Share of Drugs for Prostate Cancer by Type in 2015
Table Applications of Drugs for Prostate Cancer
Figure Global Consumption Volume Market Share of Drugs for Prostate Cancer by Application in 2015
Figure Market Share of Drugs for Prostate Cancer by Regions
Figure North America Drugs for Prostate Cancer Market Size (2011-2021)
Figure China Drugs for Prostate Cancer Market Size (2011-2021)
Figure Europe Drugs for Prostate Cancer Market Size (2011-2021)
Figure Southeast Asia Drugs for Prostate Cancer Market Size (2011-2021)
Figure Japan Drugs for Prostate Cancer Market Size (2011-2021)
Figure India Drugs for Prostate Cancer Market Size (2011-2021)
Table Drugs for Prostate Cancer Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Drugs for Prostate Cancer in 2015
Figure Manufacturing Process Analysis of Drugs for Prostate Cancer
Figure Industry Chain Structure of Drugs for Prostate Cancer
Table Capacity (Kg) and Commercial Production Date of Global Drugs for Prostate Cancer Major Manufacturers in 2015
Table Manufacturing Plants Distribution of Global Drugs for Prostate Cancer Major Manufacturers in 2015
Table R&D Status and Technology Source of Global Drugs for Prostate Cancer Major Manufacturers in 2015
Table Raw Materials Sources Analysis of Global Drugs for Prostate Cancer Major Manufacturers in 2015
Table Global Capacity (Kg), Sales (Kg), Price (USD/g), Cost (USD/g), Sales Revenue (M USD) and Gross Margin of Drugs for Prostate Cancer 2011-2016
Figure Global 2011-2016E Drugs for Prostate Cancer Market Size (Volume) and Growth Rate
Figure Global 2011-2016E Drugs for Prostate Cancer Market Size (Value) and Growth Rate
Table 2011-2016E Global Drugs for Prostate Cancer Capacity and Growth Rate
Table 2015 Global Drugs for Prostate Cancer Capacity List (Company Segment)
Table 2011-2016E Global Drugs for Prostate Cancer Sales and Growth Rate
Table 2015 Global Drugs for Prostate Cancer Sales List (Company Segment)
Table 2011-2016E Global Drugs for Prostate Cancer Sales Price
Table 2015 Global Drugs for Prostate Cancer Sales Price List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption of Drugs for Prostate Cancer 2011-2016 (Kg)
Figure North America 2011-2016E Drugs for Prostate Cancer Sales Price (USD/g)
Figure North America 2015 Drugs for Prostate Cancer Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption of Drugs for Prostate Cancer 2011-2016 (Kg)
Figure China 2011-2016E Drugs for Prostate Cancer Sales Price (USD/g)
Figure China 2015 Drugs for Prostate Cancer Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption of Drugs for Prostate Cancer 2011-2016 (Kg)
Figure Europe 2011-2016E Drugs for Prostate Cancer Sales Price (USD/g)
Figure Europe 2015 Drugs for Prostate Cancer Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption of Drugs for Prostate Cancer 2011-2016 (Kg)
Figure Southeast Asia 2011-2016E Drugs for Prostate Cancer Sales Price (USD/g)
Figure Southeast Asia 2015 Drugs for Prostate Cancer Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption of Drugs for Prostate Cancer 2011-2016 (Kg)
Figure Japan 2011-2016E Drugs for Prostate Cancer Sales Price (USD/g)
Figure Japan 2015 Drugs for Prostate Cancer Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption of Drugs for Prostate Cancer 2011-2016 (Kg)
Figure India 2011-2016E Drugs for Prostate Cancer Sales Price (USD/g)
Figure India 2015 Drugs for Prostate Cancer Sales Market Share
Table Global 2011-2016E Drugs for Prostate Cancer Sales by Type
Table Different Types Drugs for Prostate Cancer Product Interview Price
Table Global 2011-2016E Drugs for Prostate Cancer Sales by Application
Table Different Application Drugs for Prostate Cancer Product Interview Price
Table Bristol-Myers Squibb Information List
Table Type I Drugs for Prostate Cancer Overview
Table Type II Drugs for Prostate Cancer Overview
Table Type III Drugs for Prostate Cancer Overview
Table 2015 Bristol-Myers Squibb Drugs for Prostate Cancer Revenue, Sales, Ex-factory Price
Figure 2015 Bristol-Myers Squibb 2015 Drugs for Prostate Cancer Business Region Distribution
Table AstraZeneca Information List
Table Type I Drugs for Prostate Cancer Overview
Table Type II Drugs for Prostate Cancer Overview
Table Type III Drugs for Prostate Cancer Overview
Table 2015 AstraZeneca Drugs for Prostate Cancer Revenue, Sales, Ex-factory Price
Figure 2015 AstraZeneca 2015 Drugs for Prostate Cancer Business Region Distribution
Table Eli Lilly Information List
Table Type I Drugs for Prostate Cancer Overview
Table Type II Drugs for Prostate Cancer Overview
Table Type III Drugs for Prostate Cancer Overview
Table 2015 Eli Lilly Drugs for Prostate Cancer Revenue, Sales, Ex-factory Price
Figure 2015 Eli Lilly 2015 Drugs for Prostate Cancer Business Region Distribution
Table Roche Information List
Table Type I Drugs for Prostate Cancer Overview
Table Type II Drugs for Prostate Cancer Overview
Table Type III Drugs for Prostate Cancer Overview
Table 2015 Roche Drugs for Prostate Cancer Revenue, Sales, Ex-factory Price
Figure 2015 Roche 2015 Drugs for Prostate Cancer Business Region Distribution
Table GSK Information List
Table Type I Drugs for Prostate Cancer Overview
Table Type II Drugs for Prostate Cancer Overview
Table Type III Drugs for Prostate Cancer Overview
Table 2015 GSK Drugs for Prostate Cancer Revenue, Sales, Ex-factory Price
Figure 2015 GSK 2015 Drugs for Prostate Cancer Business Region Distribution
Table Novartis Information List
Table Type I Drugs for Prostate Cancer Overview
Table Type II Drugs for Prostate Cancer Overview
Table Type III Drugs for Prostate Cancer Overview
Table 2015 Novartis Drugs for Prostate Cancer Revenue, Sales, Ex-factory Price
Figure 2015 Novartis 2015 Drugs for Prostate Cancer Business Region Distribution
Table Pfizer Information List
Table Type I Drugs for Prostate Cancer Overview
Table Type II Drugs for Prostate Cancer Overview
Table Type III Drugs for Prostate Cancer Overview
Table 2015 Pfizer Drugs for Prostate Cancer Revenue, Sales, Ex-factory Price
Figure 2015 Pfizer 2015 Drugs for Prostate Cancer Business Region Distribution
Table Sanofi Information List
Table Type I Drugs for Prostate Cancer Overview
Table Type II Drugs for Prostate Cancer Overview
Table Type III Drugs for Prostate Cancer Overview
Table 2015 Sanofi Drugs for Prostate Cancer Revenue, Sales, Ex-factory Price
Figure 2015 Sanofi 2015 Drugs for Prostate Cancer Business Region Distribution
Table Bayer Information List
Table Type I Drugs for Prostate Cancer Overview
Table Type II Drugs for Prostate Cancer Overview
Table Type III Drugs for Prostate Cancer Overview
Table 2015 Bayer Drugs for Prostate Cancer Revenue, Sales, Ex-factory Price
Figure 2015 Bayer 2015 Drugs for Prostate Cancer Business Region Distribution
Table Celgene Information List
Table Type I Drugs for Prostate Cancer Overview
Table Type II Drugs for Prostate Cancer Overview
Table Type III Drugs for Prostate Cancer Overview
Table 2015 Celgene Drugs for Prostate Cancer Revenue, Sales, Ex-factory Price
Figure 2015 Celgene 2015 Drugs for Prostate Cancer Business Region Distribution
Figure Global 2016-2021 Drugs for Prostate Cancer Market Size (Volume) and Growth Rate Forecast
Figure Global 2016-2021 Drugs for Prostate Cancer Market Size (Value) and Growth Rate Forecast
Figure Global 2016-2021 Drugs for Prostate Cancer Sales Price (USD/g) Forecast
Figure North America 2016-2021 Drugs for Prostate Cancer Consumption Volume and Growth Rate Forecast
Figure China 2016-2021 Drugs for Prostate Cancer Consumption Volume and Growth Rate Forecast
Figure Europe 2016-2021 Drugs for Prostate Cancer Consumption Volume and Growth Rate Forecast
Figure Southeast Asia 2016-2021 Drugs for Prostate Cancer Consumption Volume and Growth Rate Forecast
Figure Japan 2016-2021 Drugs for Prostate Cancer Consumption Volume and Growth Rate Forecast
Figure India 2016-2021 Drugs for Prostate Cancer Consumption Volume and Growth Rate Forecast
Table Global Sales Volume (Kg) of Drugs for Prostate Cancer by Types 2016-2021
Table Global Consumption Volume (Kg) of Drugs for Prostate Cancer by Applications 2016-2021
Table Traders or Distributors with Contact Information of Drugs for Prostate Cancer by Regions
Table Part of Interviewees Record List
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
